Idiopathic Duct Centric Pancreatitis in Korea: A Clinicopathological Study of 14 Cases
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Idiopathic duct centric pancreatitis (IDCP) is a subtype of autoimmune pancreatitis (AIP) that is histologically characterized by granulocytic epithelial lesion and scarce IgG4-positive cells. This subtype of AIP has not been documented in Asian countries. Methods: We reviewed 38 histologically confirmed AIP cases and classified them into lymphoplasmacytic sclerosing pancreatitis (LPSP) and IDCP. Then, clinicopathological characteristics were compared between LPSP and IDCP. Results: Fourteen cases (36.8%) were IDCP. IDCP affected younger patients more than LPSP. IDCP was associated with ulcerative colitis in 35.7% of cases, whereas LPSP was associated with IgG4-related sclerosing diseases such as cholangitis, retroperitoneal fibrosis or sialadenitis in 41.7% of cases. IDCP was microscopically characterized by neutrophilic ductoacinitis with occasional granulocytic epithelial lesions, whereas LPSP was characterized by storiform inflammatory cell-rich fibrosis and obliterative phlebitis. IgG4-positive cells were not detected in any IDCP case but more than 20 IgG4-positive cells per high-power-field were invariably detected in LPSP cases. All patients with IDCP responded dramatically to steroids without recurrence, whereas 33.3% of patients with LPSP developed recurrences. Conclusions: IDCP is clinicopathologically distinct from LPSP and can be diagnosed when neutrophilic ductoacinitis or granulocytic epithelial lesions are observed in a pancreatic biopsy under the appropriate clinical setting.
Abstract
Background: Idiopathic duct centric pancreatitis (IDCP) is a subtype of autoimmune pancreatitis (AIP) that is histologically characterized by granulocytic epithelial lesion and scarce IgG4-positive cells. This subtype of AIP has not been documented in Asian countries. Methods: We reviewed 38 histologically confirmed AIP cases and classified them into lymphoplasmacytic sclerosing pancreatitis (LPSP) and IDCP. Then, clinicopathological characteristics were compared between LPSP and IDCP. Results: Fourteen cases (36.8%) were IDCP. IDCP affected younger patients more than LPSP. IDCP was associated with ulcerative colitis in 35.7% of cases, whereas LPSP was associated with IgG4-related sclerosing diseases such as cholangitis, retroperitoneal fibrosis or sialadenitis in 41.7% of cases. IDCP was microscopically characterized by neutrophilic ductoacinitis with occasional granulocytic epithelial lesions, whereas LPSP was characterized by storiform inflammatory cell-rich fibrosis and obliterative phlebitis. IgG4-positive cells were not detected in any IDCP case but more than 20 IgG4-positive cells per high-power-field were invariably detected in LPSP cases. All patients with IDCP responded dramatically to steroids without recurrence, whereas 33.3% of patients with LPSP developed recurrences. Conclusions: IDCP is clinicopathologically distinct from LPSP and can be diagnosed when neutrophilic ductoacinitis or granulocytic epithelial lesions are observed in a pancreatic biopsy under the appropriate clinical setting.
참고문헌 (23)
- Yoshida K, "Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis", Dig Dis Sci, 40, pp.1561~1568 (1995)
- Park DH, "Recent advances in autoimmune pancreatitis", Gut, 58, pp.1680~1689 (2009)
- Sah RP, "Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis", Gastroenterology, 139, pp.140~148 (2010)
- Klöppel G, "Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions", J Gastroenterol, 45, pp.787~793 (2010)
- Chari ST, "Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document", Pancreas, 39, pp.549~554 (2010)
- Otsuki M, "Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis", J Gastroenterol, 43, pp.403~408 (2008)
- Kamisawa T, "MRCP and MRI findings in 9 patients with autoimmune pancreatitis", World J Gastroenterol, 12, pp.2919~2922 (2006)
- Klöppel G, "Chronic pancreatitis, pseudotumors and other tumor-like lesions", Mod Pathol, 20(Suppl 1), pp.S113~S131 (2007)
- Choi EK, "The Japanese diagnostic criteria for autoimmune chronic pancreatitis: is it completely satisfactory", Pancreas, 33, pp.13~19 (2006)
- Kim MH, "Diagnostic criteria for autoimmune chronic pancreatitis", J Gastroenterol, 42(Suppl 18), pp.42~49 (2007)
- Chari ST, "Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience", Clin Gastroenterol Hepatol, 4, pp.1010~1016 (2006)
- Kamisawa T, "Diagnostic criteria for autoimmune pancreatitis in Japan", World J Gastroenterol, 14, pp.4992~4994 (2008)
- Kim KP, "Diagnostic criteria for autoimmune chronic pancreatitis revisited", World J Gastroenterol, 12, pp.2487~2496 (2006)
- Kwon S, "The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus", Pancreas, 34, pp.279~286 (2007)
- Chu KE, "The role of Movat pentachrome stain and immunoglobulin G4 immunostaining in the diagnosis of autoimmune pancreatitis", Mod Pathol, 22, pp.351~358 (2009)
- Ravi K, "Inflammatory bowel disease in the setting of autoimmune pancreatitis", Inflamm Bowel Dis, 15, pp.1326~1330 (2009)
- Nve E, "Idiopathic fibrosing pancreatitis associated with ulcerative colitis", HPB, 8, pp.153~155 (2006)
- Ye BD, "Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea", Inflamm Bowel Dis, 17, pp.1901~1906 (2011)
- Janse M, "Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9", Hepatology, 53, pp.1977~1985 (2011)
- Saeki K, "IgG4-negative autoimmune pancreatitis with sclerosing cholangitis and colitis: possible association with primary sclerosing cholangitis", Intern Med, 47, pp.943~948 (2008)
- Kamisawa T, "Management strategies for autoimmune pancreatitis", Expert Opin Pharmacother, 12, pp.2149~2159 (2011)
- Pezzilli R, "Therapeutic management and clinical outcome of autoimmune pancreatitis", Scand J Gastroenterol, 46, pp.1029~1038 (2011)
- Sung-Hoon Moon, "Treatment and Relapse of Autoimmune Pancreatitis", Gut and Liver, 2(1), pp.1~7 (2008), 거트앤리버 발행위원회